SCHEMBL12468294

SCHEMBL12468294

C[C@@H]1C[C@H](N(Cc2ccccc2)Cc2ccccc2)CC[C@@H]1O.C[C@H]1C[C@@H](N(Cc2ccccc2)Cc2ccccc2)CC[C@H]1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 2/20 0.44
YTHDC1 Q96MU7 1/20 0.42
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
MAPT P10636 1/20 0.41
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
GRIN2B Q13224 1/20 0.38
RAB9A P51151 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
FUCA1 P04066 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192148 1.00 SLC18A3 (0.44) SLC18A3YTHDC1SLC6A2SLC6A4MAPT
SCHEMBL12466177 1.00 SLC18A3 (0.44) SLC18A3YTHDC1SLC6A2SLC6A4MAPT
SCHEMBL1192262 1.00 SLC18A3 (0.44) SLC18A3YTHDC1SLC6A2SLC6A4MAPT
SCHEMBL15065296 0.81 YTHDC1 (0.42) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL12465971 0.81 YTHDC1 (0.42) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL27938356 0.81 YTHDC1 (0.42) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL25341885 0.80 YTHDC1 (0.49) SLC18A3YTHDC1SLC6A2SLC6A4SLC6A3
SCHEMBL23583787 0.80 YTHDC1 (0.46) SLC18A3YTHDC1SLC6A2SLC6A4SLC6A3
SCHEMBL25111999 0.80 YTHDC1 (0.49) SLC18A3YTHDC1SLC6A2SLC6A4SLC6A3
SCHEMBL23329113 0.80 YTHDC1 (0.49) SLC18A3YTHDC1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668162-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES Novartis AG (CH) 2013-12-04 EP disclosed
WO-2012101066-A1 PYRIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101065-A2 PYRIMIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed